KZR vs SHW · $53.9M cap vs P/E 29, rev $12.46B
Kezar Life Sciences Inc (KZR) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
Latest reported SHW revenue for 2026-06-30 was $12.46B. Net income was $1.38B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
KZR currently screens at market cap $53.9M. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the KZR and SHW stock pages for the full models.
Not investment advice.